A citation-based method for searching scientific literature

Joan L Bottorff, Pamela A Ratner, Lynda G Balneaves, Chris G Richardson, Mary McCullum, Tom Hack, Karen Chalmers, Jane Buxton. Cancer Epidemiol Biomarkers Prev 2002
Times Cited: 61







List of co-cited articles
324 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Attitudes about genetic testing for breast-ovarian cancer susceptibility.
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
427
32


BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
602
26

Interest in genetic testing among first-degree relatives of breast cancer patients.
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
262
24


Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
J P Struewing, C Lerman, R G Kase, T R Giambarresi, M A Tucker. Cancer Epidemiol Biomarkers Prev 1995
184
21

Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.
S J Durfy, D J Bowen, A McTiernan, J Sporleder, W Burke. Cancer Epidemiol Biomarkers Prev 1999
145
21



Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.
M Cappelli, L Surh, L Humphreys, S Verma, D Logan, A Hunter, J Allanson. Clin Genet 1999
91
18


Likelihood of undergoing genetic testing for cancer risk: a population-based study.
K Bosompra, B S Flynn, T Ashikaga, C J Rairikar, J K Worden, L J Solomon. Prev Med 2000
59
18

Awareness and attitudes concerning BRCA gene testing.
A Mogilner, M Otten, J D Cunningham, S T Brower. Ann Surg Oncol 1998
48
20

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
271
16

Decision-making about genetic testing among women at familial risk for breast cancer.
P B Jacobsen, H B Valdimarsdottier, K L Brown, K Offit. Psychosom Med 1997
128
16

Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families.
B B Biesecker, N Ishibe, D W Hadley, T R Giambarresi, R G Kase, C Lerman, J P Struewing. Am J Med Genet 2000
91
16


Hereditary cancer risk notification and testing: how interested is the general population?
M A Andrykowski, R Lightner, J L Studts, R K Munn. J Clin Oncol 1997
59
15


Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk.
C Hughes, A Gomez-Caminero, J Benkendorf, J Kerner, C Isaacs, J Barter, C Lerman. Patient Educ Couns 1997
163
13

Women's receptivity to testing for a genetic susceptibility to breast cancer.
H Chaliki, S Loader, J C Levenkron, W Logan-Young, W J Hall, P T Rowley. Am J Public Health 1995
128
13

Interest in BRCA1/2 testing in a primary care population.
Katrina Armstrong, Barbara Weber, Peter A Ubel, Carmen Guerra, J Sanford Schwartz. Prev Med 2002
53
15

Psychosocial aspects of cancer genetics: women at high risk for breast and ovarian cancer.
K M Kash, K Ortega-Verdejo, M K Dabney, J C Holland, D G Miller, M P Osborne. Semin Surg Oncol 2000
33
24

Genetic testing in families with hereditary nonpolyposis colon cancer.
C Lerman, C Hughes, B J Trock, R E Myers, D Main, A Bonney, M R Abbaszadegan, A E Harty, B A Franklin, J F Lynch,[...]. JAMA 1999
175
13

Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer.
O Bratt, J E Damber, M Emanuelsson, U Kristoffersson, R Lundgren, H Olsson, H Grönberg. Eur J Cancer 2000
92
13

Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
L G Bluman, B K Rimer, D A Berry, N Borstelmann, J D Iglehart, K Regan, J Schildkraut, E P Winer. J Clin Oncol 1999
105
13

Uptake rates for breast cancer genetic testing: a systematic review.
Mary E Ropka, Jennifer Wenzel, Elayne K Phillips, Mir Siadaty, John T Philbrick. Cancer Epidemiol Biomarkers Prev 2006
113
13

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.
E J Meijers-Heijboer, L C Verhoog, C T Brekelmans, C Seynaeve, M M Tilanus-Linthorst, A Wagner, L Dukel, P Devilee, A M van den Ouweland, A N van Geel,[...]. Lancet 2000
224
11

Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women.
M D Schwartz, J Benkendorf, C Lerman, C Isaacs, A Ryan-Robertson, L Johnson. Cancer 2001
72
11

Factors associated with decisions about clinical BRCA1/2 testing.
K Armstrong, K Calzone, J Stopfer, G Fitzgerald, J Coyne, B Weber. Cancer Epidemiol Biomarkers Prev 2000
102
11

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
11

Factors influencing intention to obtain a genetic test for colon cancer risk: a population-based study.
Janice Yanushka Bunn, Kwadwo Bosompra, Takamaru Ashikaga, Brian S Flynn, John K Worden. Prev Med 2002
61
11

Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK.
Saskia C Sanderson, Jane Wardle, Martin J Jarvis, Steve E Humphries. Prev Med 2004
60
11

Awareness of breast cancer genetics and interest in predictive genetic testing: a survey of a southern Italian population.
M Bruno, S Tommasi, B Stea, M Quaranta, F Schittulli, A Mastropasqua, A Distante, L Di Paola, A Paradiso. Ann Oncol 2004
18
38

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
11


Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
9

Interest in genetic testing among first-degree relatives of colorectal cancer patients.
A Y Kinney, Y A Choi, B DeVellis, E Kobetz, R C Millikan, R S Sandler. Am J Prev Med 2000
39
15

Intention to pursue genetic testing for breast cancer among women due for screening mammography.
Karin Gwyn, Sally W Vernon, Patrick M Conoley. Cancer Epidemiol Biomarkers Prev 2003
36
16


Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
9

The influence of psychological distress on use of genetic testing for cancer risk.
C Lerman, M D Schwartz, T H Lin, C Hughes, S Narod, H T Lynch. J Consult Clin Psychol 1997
139
8


Intention to be tested for prostate cancer risk among African-American men.
R E Myers, T Hyslop, K Jennings-Dozier, T A Wolf, D Y Burgh, J A Diehl, C Lerman, G W Chodak. Cancer Epidemiol Biomarkers Prev 2000
56
8


Attitudes toward colon cancer gene testing: factors predicting test uptake.
A M Codori, G M Petersen, D L Miglioretti, E K Larkin, M T Bushey, C Young, J D Brensinger, K Johnson, J A Bacon, S V Booker. Cancer Epidemiol Biomarkers Prev 1999
122
8

Genetic testing: psychological aspects and implications.
Caryn Lerman, Robert T Croyle, Kenneth P Tercyak, Heidi Hamann. J Consult Clin Psychol 2002
175
8

Attitudes towards cancer predictive testing and transmission of information to the family.
C Julian-Reynier, F Eisinger, P Vennin, F Chabal, Y Aurran, C Noguès, Y J Bignon, M Machelard-Roumagnac, C Maugard-Louboutin, D Serin,[...]. J Med Genet 1996
100
8


Why do women attend familial breast cancer clinics?
K Brain, J Gray, P Norman, E Parsons, A Clarke, C Rogers, R Mansel, P Harper. J Med Genet 2000
85
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.